Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis

Cytokine

Volumn 73, Issue 1, 2015, Pages 36-43

  Filková, Mária ^a   Vernerová, Zdenka ^b   Hulejová, Hana ^a   Prajzlerová, Klára ^a   Veigl, David ^b   Pavelka, Karel ^a,b   Vencovský, Jiří ^a,b   Šenolt, Ladislav ^a,b  

^a INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Inflammation; Interleukin 35; Rheumatoid arthritis; Synovial tissue

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 1BETA; INTERLEUKIN 27; INTERLEUKIN 35; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN EBI3; PROTEIN P35; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; EBI3 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN; PROTEIN SUBUNIT;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MACROPHAGE; OSTEOARTHRITIS; PATHOGENESIS; PROTEIN EXPRESSION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; UPREGULATION; ANIMAL; DRUG EFFECTS; GENETICS; METABOLISM; MONONUCLEAR CELL; MOUSE; PATHOLOGY; PROTEIN SUBUNIT;

ERAGROSTIS TEF; MURINAE;

ANIMALS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; FIBROBLASTS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MICE; PROTEIN SUBUNITS; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84922988798     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.01.019     Document Type: Article

References (34)

1. Klareskog L., Catrina A.I., Paget S. Rheumatoid arthritis. Lancet 2009, 373:659-672.
2. Smolen J.S., Aletaha D. The assessment of disease activity in rheumatoid arthritis. Clin Exp Rheumatol 2010, 28:S18-S27.
3. Senolt L., Vencovsky J., Pavelka K., Ospelt C., Gay S. Prospective new biological therapies for rheumatoid arthritis. Autoimmun Rev 2009, 9:102-107.
4. Collison L.W., Vignali D.A. Interleukin-35: odd one out or part of the family?. Immunol Rev 2008, 226:248-262.
5. Collison L.W., Delgoffe G.M., Guy C.S., Vignali K.M., Chaturvedi V., Fairweather D., et al. The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol 2012, 13:290-299.
6. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003, 3:133-146.
7. Bardel E., Larousserie F., Charlot-Rabiega P., Coulomb-L'Hermine A., Devergne O. Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. J Immunol 2008, 181:6898-6905.
8. Devergne O., Birkenbach M., Kieff E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA 1997, 94:12041-12046.
9. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.
10. Niedbala W., Wei X.Q., Cai B., Hueber A.J., Leung B.P., McInnes I.B., et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007, 37:3021-3029.
11. Collison L.W., Chaturvedi V., Henderson A.L., Giacomin P.R., Guy C., Bankoti J., et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 2010, 11:1093-1101.
12. Wang R.X., Yu C.R., Dambuza I.M., Mahdi R.M., Dolinska M.B., Sergeev Y.V., et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med 2014, 20:633-641.
13. Kochetkova I., Golden S., Holderness K., Callis G., Pascual D.W. IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J Immunol 2010, 184:7144-7153.
14. Kuo J., Nardelli D.T., Warner T.F., Callister S.M., Schell R.F. Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol: CVI 2011, 18:1125-1132.
15. Thiolat A., Denys A., Petit M., Biton J., Lemeiter D., Herve R., et al. Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice. Cytokine 2014, 69:87-93.
16. Allan S.E., Song-Zhao G.X., Abraham T., McMurchy A.N., Levings M.K. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur J Immunol 2008, 38:3282-3289.
17. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
18. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the American Rheumatism Association. Arthritis Rheum 1986, 29:1039-1049.
19. Taylor W., Gladman D., Helliwell P., Marchesoni A., Mease P., Mielants H., et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54:2665-2673.
20. Senolt L., Housa D., Vernerova Z., Jirasek T., Svobodova R., Veigl D., et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 2007, 66:458-463.
21. Morita Y., Yamamura M., Nishida K., Harada S., Okamoto H., Inoue H., et al. Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis. Arthritis Rheum 1998, 41:306-314.
22. Brentano F., Ospelt C., Stanczyk J., Gay R.E., Gay S., Kyburz D. Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis. Ann Rheum Dis 2009, 68:143-150.
23. Devergne O., Coulomb-L'Hermine A., Capel F., Moussa M., Capron F. Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am J Pathol 2001, 159:1763-1776.
24. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 2002, 16:779-790.
25. Kempe S., Kestler H., Lasar A., Wirth T. NF-kappaB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program. Nucleic Acids Res 2005, 33:5308-5319.
26. Larousserie F., Pflanz S., Coulomb-L'Hermine A., Brousse N., Kastelein R., Devergne O. Expression of IL-27 in human Th1-associated granulomatous diseases. J Pathol 2004, 202:164-171.
27. Niedobitek G., Pazolt D., Teichmann M., Devergne O. Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells. J Pathol 2002, 198:310-316.
28. Larousserie F., Bardel E., Coulomb L'Hermine A., Canioni D., Brousse N., Kastelein R.A., et al. Variable expression of Epstein-Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas. J Pathol 2006, 209:360-368.
29. Kempe S., Heinz P., Kokai E., Devergne O., Marx N., Wirth T. Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques. Am J Pathol 2009, 175:440-447.
30. Goriely S., Molle C., Nguyen M., Albarani V., Haddou N.O., Lin R., et al. Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood 2006, 107:1078-1084.
31. Wirtz S., Becker C., Fantini M.C., Nieuwenhuis E.E., Tubbe I., Galle P.R., et al. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. J Immunol 2005, 174:2814-2824.
32. Niedbala W., Cai B., Wei X., Patakas A., Leung B.P., McInnes I.B., et al. Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis 2008, 67:1474-1479.
33. Cao Y., Doodes P.D., Glant T.T., Finnegan A. IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J Immunol 2008, 180:922-930.
34. Rajaiah R., Puttabyatappa M., Polumuri S.K., Moudgil K.D. Interleukin-27 and interferon-gamma are involved in regulation of autoimmune arthritis. J Biol Chem 2011, 286:2817-2825.